An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers
Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent rea...
Gespeichert in:
Veröffentlicht in: | Human brain mapping 2018-01, Vol.39 (1), p.319-331 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 331 |
---|---|
container_issue | 1 |
container_start_page | 319 |
container_title | Human brain mapping |
container_volume | 39 |
creator | Hawkins, Peter C.T. Wood, Tobias C. Vernon, Anthony C. Bertolino, Alessandro Sambataro, Fabio Dukart, Juergen Merlo‐Pich, Emilio Risterucci, Celine Silber‐Baumann, Hanna Walsh, Eamonn Mazibuko, Ndabezinhle Zelaya, Fernando O. Mehta, Mitul A. |
description | Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc. |
doi_str_mv | 10.1002/hbm.23844 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6866296</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1972998340</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</originalsourceid><addsrcrecordid>eNp1kc1u1DAUhS0EoqWw4AWQJVYs0vovTrxBaiugSEVsYG05zs3ElWMPtjPVPAjvi8uUESxY-Uj-dM699yD0mpJzSgi7mIflnPFeiCfolBLVNYQq_vRBy7ZRoqMn6EXOd4RQ2hL6HJ0wRdqet_0p-nkZsAs7yMVtTHEx4DjhBJuqjMcWEgypisHHOOLJx3tswoiLy3kFnEtabVkTYDubsIGMzVQgYWPXAtiMiwuuMkdfE4rb5r2dY3E211w8g_Fl3uPFeMC76NdQAFJ-iZ5Nxmd49fieoe8fP3y7vmluv376fH1521ghuGh6O0nLlW0Zo5RLIsZukKTnjEkxSmFgFD2rF5oGVbdtDWeEE0EIdMoMkhp-ht4ffLfrsMBoIdRpvd4mt5i019E4_e9PcLPexJ2WvZRMyWrw9tEgxR9rvaK-i2uqp8uaqo6pmitIpd4dKJtizgmmYwIl-qFBXRvUvxus7Ju_RzqSfyqrwMUBuHce9v930jdXXw6WvwDFWqjm</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1972998340</pqid></control><display><type>article</type><title>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</title><source>MEDLINE</source><source>Wiley Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Hawkins, Peter C.T. ; Wood, Tobias C. ; Vernon, Anthony C. ; Bertolino, Alessandro ; Sambataro, Fabio ; Dukart, Juergen ; Merlo‐Pich, Emilio ; Risterucci, Celine ; Silber‐Baumann, Hanna ; Walsh, Eamonn ; Mazibuko, Ndabezinhle ; Zelaya, Fernando O. ; Mehta, Mitul A.</creator><creatorcontrib>Hawkins, Peter C.T. ; Wood, Tobias C. ; Vernon, Anthony C. ; Bertolino, Alessandro ; Sambataro, Fabio ; Dukart, Juergen ; Merlo‐Pich, Emilio ; Risterucci, Celine ; Silber‐Baumann, Hanna ; Walsh, Eamonn ; Mazibuko, Ndabezinhle ; Zelaya, Fernando O. ; Mehta, Mitul A.</creatorcontrib><description>Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.</description><identifier>ISSN: 1065-9471</identifier><identifier>EISSN: 1097-0193</identifier><identifier>DOI: 10.1002/hbm.23844</identifier><identifier>PMID: 29058358</identifier><language>eng</language><publisher>United States: John Wiley & Sons, Inc</publisher><subject>acute ; Acute effects ; Adult ; Antipsychotic Agents - blood ; Antipsychotic Agents - pharmacology ; Antipsychotics ; Artefacts ; Benzodiazepines - blood ; Benzodiazepines - pharmacology ; Blood flow ; Blood pressure ; Brain ; Brain - diagnostic imaging ; Brain - drug effects ; Brain - physiology ; Brain Mapping ; CBF ; Cerebral blood flow ; Cerebrovascular Circulation - drug effects ; Cerebrovascular Circulation - physiology ; Clinical trials ; Cross-Over Studies ; Dose-Response Relationship, Drug ; Double-Blind Method ; Drug dosages ; Drugs ; Haloperidol ; Haloperidol - blood ; Haloperidol - pharmacology ; Humans ; Image acquisition ; Magnetic Resonance Imaging ; Male ; Males ; Mental disorders ; Neostriatum ; Neuroimaging ; Olanzapine ; Psychotropic drugs ; relaxometry ; Risperidone ; Risperidone - blood ; Risperidone - pharmacology ; Schizophrenia ; structural MRI ; Young Adult</subject><ispartof>Human brain mapping, 2018-01, Vol.39 (1), p.319-331</ispartof><rights>2017 Wiley Periodicals, Inc.</rights><rights>2018 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</citedby><cites>FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</cites><orcidid>0000-0002-2256-1648</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866296/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6866296/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,27924,27925,45574,45575,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29058358$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hawkins, Peter C.T.</creatorcontrib><creatorcontrib>Wood, Tobias C.</creatorcontrib><creatorcontrib>Vernon, Anthony C.</creatorcontrib><creatorcontrib>Bertolino, Alessandro</creatorcontrib><creatorcontrib>Sambataro, Fabio</creatorcontrib><creatorcontrib>Dukart, Juergen</creatorcontrib><creatorcontrib>Merlo‐Pich, Emilio</creatorcontrib><creatorcontrib>Risterucci, Celine</creatorcontrib><creatorcontrib>Silber‐Baumann, Hanna</creatorcontrib><creatorcontrib>Walsh, Eamonn</creatorcontrib><creatorcontrib>Mazibuko, Ndabezinhle</creatorcontrib><creatorcontrib>Zelaya, Fernando O.</creatorcontrib><creatorcontrib>Mehta, Mitul A.</creatorcontrib><title>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</title><title>Human brain mapping</title><addtitle>Hum Brain Mapp</addtitle><description>Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.</description><subject>acute</subject><subject>Acute effects</subject><subject>Adult</subject><subject>Antipsychotic Agents - blood</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Antipsychotics</subject><subject>Artefacts</subject><subject>Benzodiazepines - blood</subject><subject>Benzodiazepines - pharmacology</subject><subject>Blood flow</subject><subject>Blood pressure</subject><subject>Brain</subject><subject>Brain - diagnostic imaging</subject><subject>Brain - drug effects</subject><subject>Brain - physiology</subject><subject>Brain Mapping</subject><subject>CBF</subject><subject>Cerebral blood flow</subject><subject>Cerebrovascular Circulation - drug effects</subject><subject>Cerebrovascular Circulation - physiology</subject><subject>Clinical trials</subject><subject>Cross-Over Studies</subject><subject>Dose-Response Relationship, Drug</subject><subject>Double-Blind Method</subject><subject>Drug dosages</subject><subject>Drugs</subject><subject>Haloperidol</subject><subject>Haloperidol - blood</subject><subject>Haloperidol - pharmacology</subject><subject>Humans</subject><subject>Image acquisition</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Males</subject><subject>Mental disorders</subject><subject>Neostriatum</subject><subject>Neuroimaging</subject><subject>Olanzapine</subject><subject>Psychotropic drugs</subject><subject>relaxometry</subject><subject>Risperidone</subject><subject>Risperidone - blood</subject><subject>Risperidone - pharmacology</subject><subject>Schizophrenia</subject><subject>structural MRI</subject><subject>Young Adult</subject><issn>1065-9471</issn><issn>1097-0193</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc1u1DAUhS0EoqWw4AWQJVYs0vovTrxBaiugSEVsYG05zs3ElWMPtjPVPAjvi8uUESxY-Uj-dM699yD0mpJzSgi7mIflnPFeiCfolBLVNYQq_vRBy7ZRoqMn6EXOd4RQ2hL6HJ0wRdqet_0p-nkZsAs7yMVtTHEx4DjhBJuqjMcWEgypisHHOOLJx3tswoiLy3kFnEtabVkTYDubsIGMzVQgYWPXAtiMiwuuMkdfE4rb5r2dY3E211w8g_Fl3uPFeMC76NdQAFJ-iZ5Nxmd49fieoe8fP3y7vmluv376fH1521ghuGh6O0nLlW0Zo5RLIsZukKTnjEkxSmFgFD2rF5oGVbdtDWeEE0EIdMoMkhp-ht4ffLfrsMBoIdRpvd4mt5i019E4_e9PcLPexJ2WvZRMyWrw9tEgxR9rvaK-i2uqp8uaqo6pmitIpd4dKJtizgmmYwIl-qFBXRvUvxus7Ju_RzqSfyqrwMUBuHce9v930jdXXw6WvwDFWqjm</recordid><startdate>201801</startdate><enddate>201801</enddate><creator>Hawkins, Peter C.T.</creator><creator>Wood, Tobias C.</creator><creator>Vernon, Anthony C.</creator><creator>Bertolino, Alessandro</creator><creator>Sambataro, Fabio</creator><creator>Dukart, Juergen</creator><creator>Merlo‐Pich, Emilio</creator><creator>Risterucci, Celine</creator><creator>Silber‐Baumann, Hanna</creator><creator>Walsh, Eamonn</creator><creator>Mazibuko, Ndabezinhle</creator><creator>Zelaya, Fernando O.</creator><creator>Mehta, Mitul A.</creator><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-2256-1648</orcidid></search><sort><creationdate>201801</creationdate><title>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</title><author>Hawkins, Peter C.T. ; Wood, Tobias C. ; Vernon, Anthony C. ; Bertolino, Alessandro ; Sambataro, Fabio ; Dukart, Juergen ; Merlo‐Pich, Emilio ; Risterucci, Celine ; Silber‐Baumann, Hanna ; Walsh, Eamonn ; Mazibuko, Ndabezinhle ; Zelaya, Fernando O. ; Mehta, Mitul A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4434-8cf6c39c522113604d7b60832264d64aed482100fb98355a32030400e79ab61a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>acute</topic><topic>Acute effects</topic><topic>Adult</topic><topic>Antipsychotic Agents - blood</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Antipsychotics</topic><topic>Artefacts</topic><topic>Benzodiazepines - blood</topic><topic>Benzodiazepines - pharmacology</topic><topic>Blood flow</topic><topic>Blood pressure</topic><topic>Brain</topic><topic>Brain - diagnostic imaging</topic><topic>Brain - drug effects</topic><topic>Brain - physiology</topic><topic>Brain Mapping</topic><topic>CBF</topic><topic>Cerebral blood flow</topic><topic>Cerebrovascular Circulation - drug effects</topic><topic>Cerebrovascular Circulation - physiology</topic><topic>Clinical trials</topic><topic>Cross-Over Studies</topic><topic>Dose-Response Relationship, Drug</topic><topic>Double-Blind Method</topic><topic>Drug dosages</topic><topic>Drugs</topic><topic>Haloperidol</topic><topic>Haloperidol - blood</topic><topic>Haloperidol - pharmacology</topic><topic>Humans</topic><topic>Image acquisition</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Males</topic><topic>Mental disorders</topic><topic>Neostriatum</topic><topic>Neuroimaging</topic><topic>Olanzapine</topic><topic>Psychotropic drugs</topic><topic>relaxometry</topic><topic>Risperidone</topic><topic>Risperidone - blood</topic><topic>Risperidone - pharmacology</topic><topic>Schizophrenia</topic><topic>structural MRI</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hawkins, Peter C.T.</creatorcontrib><creatorcontrib>Wood, Tobias C.</creatorcontrib><creatorcontrib>Vernon, Anthony C.</creatorcontrib><creatorcontrib>Bertolino, Alessandro</creatorcontrib><creatorcontrib>Sambataro, Fabio</creatorcontrib><creatorcontrib>Dukart, Juergen</creatorcontrib><creatorcontrib>Merlo‐Pich, Emilio</creatorcontrib><creatorcontrib>Risterucci, Celine</creatorcontrib><creatorcontrib>Silber‐Baumann, Hanna</creatorcontrib><creatorcontrib>Walsh, Eamonn</creatorcontrib><creatorcontrib>Mazibuko, Ndabezinhle</creatorcontrib><creatorcontrib>Zelaya, Fernando O.</creatorcontrib><creatorcontrib>Mehta, Mitul A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Human brain mapping</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hawkins, Peter C.T.</au><au>Wood, Tobias C.</au><au>Vernon, Anthony C.</au><au>Bertolino, Alessandro</au><au>Sambataro, Fabio</au><au>Dukart, Juergen</au><au>Merlo‐Pich, Emilio</au><au>Risterucci, Celine</au><au>Silber‐Baumann, Hanna</au><au>Walsh, Eamonn</au><au>Mazibuko, Ndabezinhle</au><au>Zelaya, Fernando O.</au><au>Mehta, Mitul A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers</atitle><jtitle>Human brain mapping</jtitle><addtitle>Hum Brain Mapp</addtitle><date>2018-01</date><risdate>2018</risdate><volume>39</volume><issue>1</issue><spage>319</spage><epage>331</epage><pages>319-331</pages><issn>1065-9471</issn><eissn>1097-0193</eissn><abstract>Chronic administration of antipsychotic drugs has been linked to structural brain changes observed in patients with schizophrenia. Recent MRI studies have shown rapid changes in regional brain volume following just a single dose of these drugs. However, it is not clear if these changes represent real volume changes or are artefacts (“apparent” volume changes) due to drug‐induced physiological changes, such as increased cerebral blood flow (CBF). To address this, we examined the effects of a single, clinical dose of three commonly prescribed antipsychotics on quantitative measures of T1 and regional blood flow of the healthy human brain. Males (n = 42) were randomly assigned to one of two parallel groups in a double‐blind, placebo‐controlled, randomized, three‐period cross‐over study design. One group received a single oral dose of either 0.5 or 2 mg of risperidone or placebo during each visit. The other received olanzapine (7.5 mg), haloperidol (3 mg), or placebo. MR measures of quantitative T1, CBF, and T1‐weighted images were acquired at the estimated peak plasma concentration of the drug. All three drugs caused localized increases in striatal blood flow, although drug and region specific effects were also apparent. In contrast, all assessments of T1 and brain volume remained stable across sessions, even in those areas experiencing large changes in CBF. This illustrates that a single clinically relevant oral dose of an antipsychotic has no detectable acute effect on T1 in healthy volunteers. We further provide a methodology for applying quantitative imaging methods to assess the acute effects of other compounds on structural MRI metrics. Hum Brain Mapp 39:319–331, 2018. © 2017 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>John Wiley & Sons, Inc</pub><pmid>29058358</pmid><doi>10.1002/hbm.23844</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-2256-1648</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1065-9471 |
ispartof | Human brain mapping, 2018-01, Vol.39 (1), p.319-331 |
issn | 1065-9471 1097-0193 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6866296 |
source | MEDLINE; Wiley Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | acute Acute effects Adult Antipsychotic Agents - blood Antipsychotic Agents - pharmacology Antipsychotics Artefacts Benzodiazepines - blood Benzodiazepines - pharmacology Blood flow Blood pressure Brain Brain - diagnostic imaging Brain - drug effects Brain - physiology Brain Mapping CBF Cerebral blood flow Cerebrovascular Circulation - drug effects Cerebrovascular Circulation - physiology Clinical trials Cross-Over Studies Dose-Response Relationship, Drug Double-Blind Method Drug dosages Drugs Haloperidol Haloperidol - blood Haloperidol - pharmacology Humans Image acquisition Magnetic Resonance Imaging Male Males Mental disorders Neostriatum Neuroimaging Olanzapine Psychotropic drugs relaxometry Risperidone Risperidone - blood Risperidone - pharmacology Schizophrenia structural MRI Young Adult |
title | An investigation of regional cerebral blood flow and tissue structure changes after acute administration of antipsychotics in healthy male volunteers |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T04%3A54%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20investigation%20of%20regional%20cerebral%20blood%20flow%20and%20tissue%20structure%20changes%20after%20acute%20administration%20of%20antipsychotics%20in%20healthy%20male%20volunteers&rft.jtitle=Human%20brain%20mapping&rft.au=Hawkins,%20Peter%20C.T.&rft.date=2018-01&rft.volume=39&rft.issue=1&rft.spage=319&rft.epage=331&rft.pages=319-331&rft.issn=1065-9471&rft.eissn=1097-0193&rft_id=info:doi/10.1002/hbm.23844&rft_dat=%3Cproquest_pubme%3E1972998340%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1972998340&rft_id=info:pmid/29058358&rfr_iscdi=true |